Exploring the controversy of cancer-causing substances in Indian spices, particularly ETO, and the international response. Discussing FSSAI regulations on pesticide limits for herbs and spices, highlighting the challenges and impact on spice quality.
Ethylene oxide in spices raises health concerns globally, necessitating stringent quality checks and regulatory oversight.
Domestic and export spice markets face challenges in ensuring product safety, highlighting the need for improved monitoring and regulatory measures.
Deep dives
Controversy Over Cancer-Causing Substance in Indian Spices
Indian spice makers, including MDH and Everest, have come under scrutiny for the presence of ethylene oxide (ETO), a potential cancer-causing substance, in their products. This discovery has triggered bans in Singapore and Hong Kong, with the European Union and the US also investigating contaminated chilli peppers and peppercorns. ETO, primarily used to control microbial growth, has been linked to adverse health effects like organ damage and genetic harm. Despite denials from spice makers, concerns abound over the inadvertent contamination and the need for stricter quality checks by regulatory bodies.
Safety Concerns Extend Beyond Exports to Domestic Market
Apart from international scrutiny, domestic packaged spice brands in India have faced previous allegations of toxic substances like lead, posing health risks, especially for children. The Food Safety and Standards Authority of India (FSSAI), responsible for food regulations, has recently raised pesticide residue limits in herbs and spices, causing apprehension about declining product quality. Both the Spices Board and FSSAI face challenges in ensuring the safety and quality of spices, emphasizing the necessity for enhanced monitoring and regulatory measures in both export and domestic markets.